113 related articles for article (PubMed ID: 8747379)
1. Perspective on cervical cancer: why prevent?
Morrow CP; Cozen W
J Cell Biochem Suppl; 1995; 23():61-70. PubMed ID: 8747379
[TBL] [Abstract][Full Text] [Related]
2. Implementing recommendations for the early detection of breast and cervical cancer among low-income women.
Lawson HW; Henson R; Bobo JK; Kaeser MK
MMWR Recomm Rep; 2000 Mar; 49(RR-2):37-55. PubMed ID: 15580731
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
Moscicki AB; Flowers L; Huchko MJ; Long ME; MacLaughlin KL; Murphy J; Spiryda LB; Gold MA
J Low Genit Tract Dis; 2019 Apr; 23(2):87-101. PubMed ID: 30907775
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
5. [In situ and invasive cervical cancer epidemiology in the province of Girona, Spain 1990-2004: incidence, mortality, survival and screening history].
Castro Marqueta P; Moreno-Crespi J; Buxó-Pujolràs M; Cervantes-Amat M; Pérez-Gómez B; Marcos-Gragera R
Med Clin (Barc); 2011 Feb; 136(5):192-8. PubMed ID: 21051058
[TBL] [Abstract][Full Text] [Related]
6. [CERVICAL CANCER IN ISRAEL 2016: FACTS, INSIGHTS AND THOUGHTS FOR THE FUTURE].
Fisher M; Schejter E; Solt I; Renart G
Harefuah; 2016 Sep; 155(9):563-566. PubMed ID: 28530082
[TBL] [Abstract][Full Text] [Related]
7. Assessing the feasibility of single lifetime PAP smear evaluation between 41-50 years of age as strategy for cervical cancer control in developing countries from our 32 years of experience of hospital-based routine cytological screening.
Misra JS; Gupta HP; Das V
Diagn Cytopathol; 2004 Dec; 31(6):376-9. PubMed ID: 15540174
[TBL] [Abstract][Full Text] [Related]
8. Detection of preinvasive cancer of the cervix and the subsequent reduction in invasive cancer.
Bergström R; Adami HO; Gustafsson L; Pontén J; Sparén P
J Natl Cancer Inst; 1993 Jul; 85(13):1050-7. PubMed ID: 8515491
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of cervical cancer: screening, progress and perspectives].
Monsonego J
Presse Med; 2007 Jan; 36(1 Pt 2):92-111. PubMed ID: 17296477
[TBL] [Abstract][Full Text] [Related]
10. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
12. Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative pap smears.
van Oortmarssen GJ; Habbema JD
Int J Epidemiol; 1995 Apr; 24(2):300-7. PubMed ID: 7635589
[TBL] [Abstract][Full Text] [Related]
13. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
14. [Cervical cancer screening and associated treatment costs in France].
Bergeron C; Breugelmans JG; Bouée S; Lorans C; Bénard S; Rémy V
Gynecol Obstet Fertil; 2006 Nov; 34(11):1036-42. PubMed ID: 17070085
[TBL] [Abstract][Full Text] [Related]
15. Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence.
Anttila A; Pukkala E; Söderman B; Kallio M; Nieminen P; Hakama M
Int J Cancer; 1999 Sep; 83(1):59-65. PubMed ID: 10449609
[TBL] [Abstract][Full Text] [Related]
16. Medicolegal affairs. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
Frable WJ; Austin RM; Greening SE; Collins RJ; Hillman RL; Kobler TP; Koss LG; Mitchell H; Perey R; Rosenthal DL; Sidoti MS; Somrak TM
Acta Cytol; 1998; 42(1):76-119; discussion 120-32. PubMed ID: 9479326
[TBL] [Abstract][Full Text] [Related]
17. Effect of the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88) on the incidence of invasive cervical cancer.
Helfand M; O'Connor GT; Zimmer-Gembeck M; Beck JR
Med Care; 1992 Dec; 30(12):1067-82. PubMed ID: 1453813
[TBL] [Abstract][Full Text] [Related]
18. Cervical cancers diagnosed after negative results on cervical cytology: perspective in the 1980s.
Mitchell H; Medley G; Giles G
BMJ; 1990 Jun; 300(6740):1622-6. PubMed ID: 2372641
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
